Search

Hong Li

from Ithaca, NY
Age ~62
Get Report
Also known as:
Weihong Li, Li Weihong, Hong Chen, Hong Liu
Phone and address:
510 The Pkwy, Ithaca, NY 14850
(607) 319-0266
Related to:
Yong Chen
Connected to:
Ai Q Li, 64Ai H Li, 81Aida Li, 67Aijun Li, 65Aiwen Q Li, 56Aiyan Li, 61Alan Li, 80Alice Li, 46Alida Li, 59Alisha Li, 31

Hong Li Phones & Addresses

  • 510 The Pkwy, Ithaca, NY 14850 (607) 319-0266
  • Burke, VA
  • Princeton, NJ
  • Tompkins, NY

Professional Records

Lawyers & Attorneys

Hong Li Photo 1

Hong Li - Lawyer

View page
Address:
China International Capital Corporation Limited
(106) 505-1166 (Office)
Licenses:
New York - Currently registered 2010
Education:
Columbia Law School
Hong Li Photo 2

Hong Li - Lawyer

View page
Address:
Han Kun Law Offices
(381) 003-3462 (Office)
Licenses:
New York - Currently registered 2011
Education:
The University of Texas School of Law
Hong Li Photo 3

Hong Li - Lawyer

View page
Specialties:
Business Law
Real Property Law
Privacy Law
ISLN:
1000865076
Admitted:
2019

Medicine Doctors

Hong Li Photo 4

Hong Li

View page
Specialties:
Family Medicine
Work:
Doctor Lis Family Care
3576 Shallowford Rd NE STE A, Atlanta, GA 30341
(770) 451-9940 (phone), (770) 451-6996 (fax)
Education:
Medical School
Capital Univ of Med Scis, Training Ctr of Gen Prac, Beijing City, China
Graduated: 1983
Procedures:
Arthrocentesis
Electrocardiogram (EKG or ECG)
Hearing Evaluation
Pulmonary Function Tests
Vaccine Administration
Conditions:
Acute Pharyngitis
Acute Upper Respiratory Tract Infections
Allergic Rhinitis
Anemia
Atopic Dermatitis
Languages:
Chinese
English
Spanish
Description:
Dr. Li graduated from the Capital Univ of Med Scis, Training Ctr of Gen Prac, Beijing City, China in 1983. She works in Chamblee, GA and specializes in Family Medicine. Dr. Li is affiliated with Dekalb Medical At North Decatur.
Hong Li Photo 5

Hong Li

View page
Specialties:
Pediatrics
Work:
Li Hong MD PLLC
14212 41 Ave APT L1, Flushing, NY 11355
(917) 285-2148 (phone), (917) 720-9988 (fax)
Education:
Medical School
Tongji Med Univ, Wuhan City, Hubei, China
Graduated: 1993
Procedures:
Hearing Evaluation
Nutrition Therapy
Psychological and Neuropsychological Tests
Vaccine Administration
Conditions:
Acute Bronchitis
Acute Upper Respiratory Tract Infections
Atopic Dermatitis
Constipation
Vitamin D Deficiency
Languages:
Chinese
English
Description:
Dr. Li graduated from the Tongji Med Univ, Wuhan City, Hubei, China in 1993. She works in Flushing, NY and specializes in Pediatrics. Dr. Li is affiliated with Lutheran Medical Center and New York Presbyterian Lower Manhattan Hospital.
Hong Li Photo 6

Hong Li

View page
Specialties:
Genetics, Medical
Work:
Emory ClinicEmory Clinic Human Genetics
2165 N Decatur Rd STE 100, Decatur, GA 30033
(404) 778-8570 (phone), (404) 778-8562 (fax)
Education:
Medical School
Hebei Med Univ, Shi Jiazhuang City, Hebei, China
Graduated: 1994
Languages:
Arabic
English
Italian
Portuguese
Spanish
Description:
Dr. Li graduated from the Hebei Med Univ, Shi Jiazhuang City, Hebei, China in 1994. She works in Decatur, GA and specializes in Genetics, Medical. Dr. Li is affiliated with Childrens Hospital Of Macon and Emory University Hospital.
Hong Li Photo 7

Hong C. Li

View page
Specialties:
Anatomic Pathology & Clinical Pathology
Work:
Greensboro Pathology AssocsGreensboro Pathology Associates
706 Grn Vly Rd STE 104, Greensboro, NC 27408
(800) 345-3376 (phone), (336) 387-2501 (fax)
Education:
Medical School
Shanghai Med Univ, Shanghai First Med Univ, Shanghai, China
Graduated: 1992
Languages:
English
Description:
Dr. Li graduated from the Shanghai Med Univ, Shanghai First Med Univ, Shanghai, China in 1992. She works in Greensboro, NC and specializes in Anatomic Pathology & Clinical Pathology. Dr. Li is affiliated with Moses H Cone Memorial Hospital and Wesley Long Hospital.
Hong Li Photo 8

Hong Li

View page
Specialties:
Anesthesiology
Work:
Oregon Anesthesiology GroupOregon Anesthesiology Group PC
601 NW Elks Dr, Corvallis, OR 97330
(503) 299-9906 (phone), (503) 295-2232 (fax)

Oregon Anesthesiology Group
707 SW Washington St STE 700, Portland, OR 97205
(503) 299-9906 (phone), (503) 295-2232 (fax)
Education:
Medical School
Shandong Med Univ, Jinan, Shandong, China (242 46 Prior 1 1 71)
Graduated: 1982
Languages:
English
Description:
Dr. Li graduated from the Shandong Med Univ, Jinan, Shandong, China (242 46 Prior 1 1 71) in 1982. She works in Portland, OR and 1 other location and specializes in Anesthesiology. Dr. Li is affiliated with Good Samaritan Regional Medical Center, Legacy Meridian Park Hospital and Legacy Mount Hood Medical Center.
Hong Li Photo 9

Hong Li

View page
Specialties:
Internal Medicine
Work:
Essentia Health St Josephs Brainerd Clinic
2024 S 6 St, Brainerd, MN 56401
(218) 828-7100 (phone), (218) 855-5491 (fax)
Education:
Medical School
Shanghai Med Univ, Shanghai First Med Univ, Shanghai, China
Graduated: 1985
Languages:
English
Description:
Dr. Li graduated from the Shanghai Med Univ, Shanghai First Med Univ, Shanghai, China in 1985. She works in Brainerd, MN and specializes in Internal Medicine.
Hong Li Photo 10

Hong Li

View page
Specialties:
Anatomic Pathology & Clinical Pathology
Work:
Lab Corporation
605 E Huntington Dr STE 209, Monrovia, CA 91016
(800) 468-7088 (phone), (626) 359-0752 (fax)
Education:
Medical School
Beijing Med Univ, Beijing City, Beijing, China
Graduated: 1984
Languages:
English
Description:
Dr. Li graduated from the Beijing Med Univ, Beijing City, Beijing, China in 1984. She works in Monrovia, CA and specializes in Anatomic Pathology & Clinical Pathology.
Hong Li Photo 11

Hong Li

View page
Specialties:
Oral & Maxillofacial Surgery
Work:
Willamette Dental Group
11011 Meridian Ave N STE 104, Seattle, WA 98133
(206) 365-0378 (phone), (206) 365-0398 (fax)
Languages:
Chinese
English
Description:
Dr. Li works in Seattle, WA and specializes in Oral & Maxillofacial Surgery.

Resumes

Resumes

Hong Li Photo 12

Hong Li Potomac, MD

View page
Work:
Animal Modeling of Ocular Diseases, Wellstat Ophthalmics Corporation
Gaithersburg, MD
2009 to Feb 2013
Research Associate
Penn State College of Medicine
Hershey, PA
2007 to 2008
Post Doc Research Associate
Yale University
New Haven, CT
2003 to 2006
Post Doc Research Associate
University of Louisville
Louisville, KY
2001 to 2003
Post Doc Research Associate
Section of Ophthalmology, Beijing University Shenzhen Hospital
Shenzhen, China
1998 to 2001
Attending physician (Ophthalmology)
Zibo Central Hospital
Zibo, CN
1992 to 1995
Resident (Ophthalmology)
Zibo Vocational Institute
Zibo, China
1992 to 1995
Instructor (Ophthalmology)
Education:
Sun Yat-Sen University
Guangzhou, CN
1995 to 1998
M.Sci in Ocular pathology
Weifang Medical College
Weifang, CN
1987 to 1992
Bachelor of Medicine (equivalent to MD) in Clinical medicine
Skills:
Computer Skills Microsoft office suites; GraphPad Prism; Image Pro Plus 6.1; Adobe Photoshop (CS4)

Business Records

Name / Title
Company / Classification
Phones & Addresses
Hong Li
Director
SL INVEST, LLC
Hong Li
NEW YUN TUNG INC
Hong Li
CINPAC INC

Publications

Us Patents

Cetp Inhibitors

View page
US Patent:
7652049, Jan 26, 2010
Filed:
Jul 1, 2005
Appl. No.:
11/173295
Inventors:
Amjad Ali - Freehold NJ, US
Joann M. Napolitano - Woodbridge NJ, US
Qiaolin Deng - Edison NJ, US
Zhijian Lu - Clinton NJ, US
Peter J. Sinclair - Scotch Plains NJ, US
Gayle E. Taylor - Jersey City NJ, US
Christopher F. Thompson - Clark NJ, US
Nazia Quraishi - Arlington MA, US
Cameron J. Smith - Lawrenceville NJ, US
Julianne A. Hunt - Scotch Plains NJ, US
Adrian A. Dowst - Hoboken NJ, US
Yi-Heng Chen - Whippany NJ, US
Hong Li - Edison NJ, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C07D 263/20
A61K 31/4015
US Classification:
514376, 514340, 514361, 514386, 5462714, 548125, 548224, 5483661
Abstract:
Compounds having the structures of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis:.

Cetp Inhibitors

View page
US Patent:
7910592, Mar 22, 2011
Filed:
Dec 29, 2006
Appl. No.:
12/087185
Inventors:
Amjad Ali - Freehold NJ, US
Zhijian Lu - Clinton NJ, US
Peter J. Sinclair - Scotch Plains NJ, US
Yi-Heng Chen - Whippany NJ, US
Cameron J. Smith - Lawrenceville NJ, US
Hong Li - Edison NJ, US
Christopher F. Thompson - Clark NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/497
A61K 31/427
A61K 31/422
A61K 31/506
C07D 239/02
C07D 241/02
C07D 401/02
C07D 277/02
C07D 263/02
US Classification:
51425505, 514256, 514365, 514376, 544242, 544336, 5462714, 548202, 548230
Abstract:
Compounds having the structure of Formula (I), including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compounds of Formula (I), B is a cyclic group other than phenyl, and B has a cyclic substituent at a position that is ortho to the position at which B is connected to the remainder of the structure of Formula (I). The 5-membered ring of Formula (I) has a second cyclic substituent in addition to B.

1,3-Oxazolidin-2-One Derivatives Useful As Cetp Inhibitors

View page
US Patent:
7915271, Mar 29, 2011
Filed:
Dec 29, 2006
Appl. No.:
12/087290
Inventors:
Amjad Ali - Freehold NJ, US
Zhijian Lu - Clinton NJ, US
Peter J. Sinclair - Scotch Plains NJ, US
Yi-Heng Chen - Whippany NJ, US
Cameron J. Smith - Lawrenceville NJ, US
Hong Li - Edison NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/4166
A61K 31/44
A61K 31/506
C07D 239/34
C07D 413/10
C07D 263/06
US Classification:
514274, 514326, 514376, 544315, 546209, 5462714, 548229
Abstract:
Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. The compounds have 3 cyclic groups connected by single bonds, as for example triphenyl, which are attached directly to the ring of formula I or attached at the position B.

1,3-Oxazolidin -2-One Derivatives Useful As Cetp Inhibitors

View page
US Patent:
8440702, May 14, 2013
Filed:
Mar 28, 2011
Appl. No.:
13/073190
Inventors:
Amjad Ali - Freehold NJ, US
Zhijian Lu - Clinton NJ, US
Peter J. Sinclair - Scotch Plains NJ, US
Yi-Heng Chen - Whippany NJ, US
Cameron J. Smith - Lawrenceville NJ, US
Hong Li - Edison NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/4166
A61K 31/44
C07D 413/10
US Classification:
514340, 5462714
Abstract:
Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. The compounds have 3 cyclic groups connected by single bonds, as for example triphenyl, which are attached directly to the ring of formula I or attached at the position B.

Cetp Inhibitors

View page
US Patent:
20080119476, May 22, 2008
Filed:
Jul 1, 2005
Appl. No.:
11/631821
Inventors:
Amjad Ali - Freehold NJ, US
Joann M. Napolitano - Woodbridge NJ, US
Qiaolin Deng - Edison NJ, US
Zhijian Lu - Clinton NJ, US
Peter J. Sinclair - Scotch Plains NJ, US
Gayle E. Taylor - Jersey City NJ, US
Christopher F. Thompson - Clark NJ, US
Nazia Quraishi - Arlington MA, US
Cameron J. Smith - Lawrenceville NJ, US
Julianne A. Hunt - Scotch Palins NJ, US
Adrian A. Dowst - Hoboken NJ, US
Yi-Heng Chen - Whippany NJ, US
Hong Li - Edison NJ, US
International Classification:
A61K 31/422
A61K 31/40
A61K 31/4166
A61K 31/427
A61K 31/4439
A61K 31/501
A61P 9/10
C07D 233/32
C07D 263/20
C07D 417/10
C07D 417/04
C07D 413/10
C07D 413/04
C07D 401/04
C07D 285/10
C07D 233/44
C07D 207/24
A61K 31/506
A61K 31/497
A61K 31/433
A61K 31/4168
A61K 31/421
US Classification:
51425205, 51425505, 514256, 514340, 514341, 514362, 514372, 514376, 514392, 514424, 514426, 544238, 544333, 544405, 5462714, 5462741, 548134, 548200, 548229, 5483235, 5483315, 548551
Abstract:
Compounds having the structures of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis:In the compounds of Formula I, B or Ris a phenyl group which has an ortho aryl, heterocyclic, benzoheterocyclic or benzocycloalkyl substituent, and one other position on the 5-membered ring has an aromatic, heterocyclic, cycloalkyl, benzoheterocyclic or benzocycloalkyl substituent connected directly to the ring or attached to the ring through a —CH—.

Cetp Inhibitors

View page
US Patent:
20100099716, Apr 22, 2010
Filed:
Nov 25, 2009
Appl. No.:
12/625783
Inventors:
Amjad ALI - Freehold NJ, US
Joann M. Napolitano - Woodbridge NJ, US
Qiaolin Deng - Edison NJ, US
Zhijian Lu - Clinton NJ, US
Peter J. Sinclair - Scotch Plains NJ, US
Gayle E. Taylor - Jersey City NJ, US
Christopher F. Thompson - Clark NJ, US
Nazia Quraishi - Arlington MA, US
Cameron J. Smith - Lawrenceville NJ, US
Julianne A. Hunt - Scotch Plains NJ, US
Adrian A. Dowst - Hoboken NJ, US
Yi-Heng Chen - Whippany NJ, US
Hong Li - Edison NJ, US
International Classification:
A61K 31/421
C07D 263/04
C07D 413/04
A61K 31/4439
A61P 9/10
US Classification:
514340, 548229, 5462714, 514376
Abstract:
Compounds having the structures of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis:In the compounds of Formula I, B or Ris a phenyl group which has an ortho aryl, heterocyclic, benzoheterocyclic or benzocycloalkyl substituent, and one other position on the 5-membered ring has an aromatic, heterocyclic, cycloalkyl, benzoheterocyclic or benzocycloalkyl substituent connected directly to the ring or attached to the ring through a —CH—.

Compositions With Enhanced Immunogenicity And/Or Reduced Reactogenicity

View page
US Patent:
20130330367, Dec 12, 2013
Filed:
Aug 20, 2013
Appl. No.:
13/970918
Inventors:
Ge Liu - Cranbury NJ, US
Scott Umlauf - Cranbury NJ, US
Uma Kavita - Cranbury NJ, US
Hong Li - Cranbury NJ, US
Xiangyu Liu - Cranbury NJ, US
Bruce Weaver - Cranbury NJ, US
Lynda Tussey - Cranbury NJ, US
Assignee:
Vaxinnate Corporation - Cranbury NJ
International Classification:
C07K 14/195
C07K 14/005
US Classification:
4241851, 530350
Abstract:
The present invention relates to improved vaccines and the design and making of such vaccines that enhance immunogenicity of the vaccine and/or reduce reactogenicity to the vaccine when administered. In particular the vaccines and immunogenic compositions of the present invention relate to flagellin-antigen fusion proteins in which the spatial orientation of the flagellin to antigen and the charge distribution of the antigen is optimized to enhance immunogenicity and/or reduce reactogenicity. The present invention also relates to methods of evaluating the vaccines by measuring the relative expression of certain gene markers. Altered expression of the genes relative to flagellin control sample may indicate that the vaccine is suitable to stimulate an adaptive immune response to the antigen component in the subject with minimal side effects.

Cyclic Amine Substituted Oxazolidinone Cetp Inhibitor

View page
US Patent:
20130331372, Dec 12, 2013
Filed:
Oct 25, 2011
Appl. No.:
13/881896
Inventors:
Zhijian Lu - Clinton NJ, US
Yi-Heng Chen - Whippany NJ, US
Cameron Smith - Lawrenceville NJ, US
Hong Li - Edison NJ, US
Christopher F. Thompson - Arlington MA, US
Julianne Hunt - Montclair NJ, US
Florida Kallashi - Lawrence Harbor NJ, US
Ramzi Sweis - Lake Bluff IL, US
Peter Sinclair - Doylestown PA, US
Samantha E. Adamson - Charlottesville VA, US
Guizhen Dong - Dayton NJ, US
Debra L. Ondeyka - Fanwood NJ, US
Xiaoxia Qian - New York NY, US
Wanying Sun - Edison NJ, US
Petr Vachal - Summit NJ, US
Kake Zhao - Westfield NJ, US
International Classification:
C07D 491/08
A61K 31/5377
A61K 31/4545
A61K 31/444
A61K 31/497
C07D 417/14
C07D 413/14
A61K 45/06
A61K 31/4439
A61K 31/506
US Classification:
51421018, 5142102, 5142358, 514275, 514318, 514343, 544122, 544325, 544405, 546194, 546256, 5462697, 5462714
Abstract:
Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis. In the compound of Formula I, Ais a substituted phenyl group or indanyl group. Formula (I).

Isbn (Books And Publications)

Social Work Education: A Bibliography

View page
Author

Hong Chan Li

ISBN #

0810811081

Social Work Education II: A Bibliography, 1977-1987

View page
Author

Hong Chan Li

ISBN #

0810821958

Control profile
Hong Li from Ithaca, NY, age ~62 Get Report